Gene · 54210
Papers3,294
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,294
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells. | J Immunother Cancer | 2026 | 41611243 | PubTator, text mining | PubMed |
| Multi-platform integration of brain and CSF proteomes reveals biomarker panels for Alzheimer's disease. | Brief Bioinform | 2026 | 41608987 | PubTator, text mining | PubMed |
| Further Evidence for the Immunosuppressive Activity of Transmembrane Envelope Protein p15E of Porcine Endogenous Retrovirus. | Int J Mol Sci | 2026 | 41596735 | PubTator, text mining | PubMed |
| Endothelial glycocalyx degradation and its association with clinical outcomes and host response aberrations in community-acquired pneumonia across different care settings. | Crit Care | 2026 | 41593637 | PubTator, text mining | PubMed |
| Aberrant expression of triggering receptor expressed on myeloid cell-1 is involved in the immunopathological mechanism of myasthenia gravis. | Autoimmunity | 2026 | 41588655 | PubTator, text mining | PubMed |
| TREM-1 Blockade Inhibits Inflammasome Activation and Pyroptosis: Novel Insights on the Role of TREM-1 and Syk in Monosodium Urate Crystal-Induced Inflammation. | Immunology | 2026 | 41582609 | PubTator, text mining | PubMed |
| Latent tuberculosis infection in high TB disease burden countries dysregulates cellular and immunological profiles which is further enhanced with uncontrolled hyperglycemia. | Sci Rep | 2026 | 41565868 | PubTator, text mining | PubMed |
| Combining Cytokine-Related Biomarkers to Better Define Tumor Necrosis Factor-α Antagonist Response in Inflammatory Bowel Disease: An Observational Cohort Study. | Clin Transl Gastroenterol | 2026 | 41563717 | PubTator, text mining | PubMed |
| Longitudinal biomarker trajectories and their prognostic utility for 21-day mortality in burn patients with sepsis: a retrospective cohort study. | Inflamm Res | 2026 | 41563442 | PubTator, text mining | PubMed |
| Comments on "TREM1 deficiency attenuates LPS-induced sepsis-associated acute kidney injury by modulating macrophage polarization". | Int J Surg | 2026 | 41563028 | PubTator, text mining | PubMed |
A comprehensive analysis of the correlation between plasma cytokines/chemokines and tumor immune microenvironment signature influences the response of checkpoint inhibitors in advanced non-small-cell lung cancer. | Clin Transl Immunology | 2026 | 41541230 | PubTator, text mining | PubMed |
| EGFR orchestrates neutrophil activation and NETosis via CEBPβ-dependent PGLYRP1 induction. | Cell Death Differ | 2026 | 41540251 | PubTator, text mining | PubMed |
| The TREM Receptor Family in Cardiovascular Diseases: Functions, Mechanisms and Therapeutic Perspectives. | Int Immunopharmacol | 2026 | 41539000 | PubTator, text mining | PubMed |
| Phytochemicals as potential inhibitors of NETosis: implications for immunothrombosis and chronic disease management. | BMC Complement Med Ther | 2026 | 41501850 | PubTator, text mining | PubMed |
| Embelin Ameliorates DSS-Induced Ulcerative Colitis by Concurrent Inhibition of TREM-1 and PI3K/AKT Signaling Pathways. | Tohoku J Exp Med | 2026 | 41500610 | PubTator, text mining | PubMed |
| Transcriptome-wide association study of sex effects identifies sex-specific nasal epithelial gene expression profiles for total IgE. | J Allergy Clin Immunol | 2026 | 41482249 | PubTator, text mining | PubMed |
| TREM-1: A potential prognostic marker in newborns with late-onset sepsis. | Cytokine | 2026 | 41344135 | PubTator, text mining | PubMed |
| sTREM-1 as a biomarker for sepsis diagnosis and prognosis following abdominal surgery. | Lab Med | 2026 | 41273150 | PubTator, text mining | PubMed |
| The Protective Effects of the Triggering Receptor Expressed on Myeloid Cells-1 Inhibitor LP17 on Experimental Acute Brain Injury: A Systematic Review and Meta-Analysis Based on Animal Models. | J Neurotrauma | 2026 | 41250791 | PubTator, text mining | PubMed |
| TREM2 activation by first-in-class direct small molecule agonists: DEL screening, optimization, biophysical validation, and functional characterization. | Eur J Med Chem | 2026 | 41240472 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54210/papers?page=6